Loading…
Zylox-Tonbridge announced a definitive agreement to acquire Optimed Medizinische Instrumente GmbH, a Germany-based medical device company specializing in minimally invasive vascular and endourology devices. The acquisition aims to accelerate Zylox-Tonbridge's global expansion in the MedTech market.
Zylox-Tonbridge and Avinger announced a strategic partnership including exclusive rights for Zylox-Tonbridge to localize, manufacture, and commercialize Avinger's OCT product family in Greater China, a technology transfer agreement, and a $15 million investment by Zylox-Tonbridge into Avinger.